Tradestie Institutional Equity Comparison Engine

SCNI vs PLUR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SCNI Overall Edge

SCNI Captures Institutional Edge (2โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) driven by superior Growth & Margin, Momentum & Technical while PLUR counters with relative strength in Valuation. Fundamentally, SCNI trades at N/M Forward P/E with -276.1% operating margin (+572.5% YoY revenue) versus PLUR at 3.6x Forward P/E and -2454.5% operating margin (-15.8% YoY). In options structure, SCNI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PLUR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PLUR
SCNI N/M vs PLUR 3.6x Fwd P/E
Growth & Margin Winner SCNI
Op Margin -276.1% vs -2454.5% ยท YoY +572.5% vs -15.8%
Momentum & Technical Winner SCNI
1Y -61.1% vs -78.8% ยท 52W Pos 5% vs 2%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SCNI NASDAQ
Scinai Immunotherapeutics Ltd. American Depositary Shares
Biological Products, (No Disgnostic Substances)
$0.38
-5.89% 1D
Market Cap $1.1M
1M Return -49.29%
1Y Return -61.13%
Forward P/E N/M
Unified AI Score
47.3 / 100 HOLD
Tech 43.0 Fund 42.0 Flow 50.0 Mom 60.0
PLUR US Equity
Pluri Inc.
Biological Products, (No Diagnostic Substances)
$0.94
-9.19% 1D
Market Cap $15.1M
1M Return +11.09%
1Y Return -78.78%
Forward P/E 3.6x
Unified AI Score
28.8 / 100 SELL
Tech 15.0 Fund 34.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SCNI -61.13% PLUR -78.78% Spread: +14.4 pp (SCNI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SCNI TTM Op. Margin: -276.1% PLUR TTM Op. Margin: -2454.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SCNI vs PLUR. Trailing 12-month operating profitability (SCNI -276.1% vs PLUR -2454.5%) and valuation multiples (SCNI N/M vs PLUR 3.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SCNI (7) vs PLUR (3)
Institutional Metric SCNI PLUR Criterion Row Winner
Market Capitalization Scale $1.1M $15.1M Larger Scale PLUR
Trailing P/E Ratio Valuation 0.1x 3.6x Lower Multiple SCNI
Forward P/E Ratio Valuation N/M 3.6x Lower Multiple PLUR
Revenue Growth (YoY) Growth +572.5% -15.8% Higher Growth SCNI
Operating Margin (TTM) Profitability -276.1% -2454.5% Higher Margin SCNI
Net Profit Margin Profitability -80.1% 0.0% Higher Margin PLUR
Return on Equity (ROE) Capital Efficiency -26.1% -1022.0% Higher ROE SCNI
52-Week Range Position Momentum 5% ($0โ€“$4) 2% ($1โ€“$5) Stronger Trend SCNI
Beta / 30D Volatility Risk Regime 3.85ฮฒ ยท 82% Vol 0.80ฮฒ ยท 102% Vol Lower Realized Risk SCNI
Unified Institutional Score Composite Signal 47.3 / 100 (HOLD) 28.8 / 100 (SELL) Higher Composite SCNI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SCNI vs PLUR Buy Guide
SCNI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SCNI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PLUR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PLUR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SCNI nor PLUR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.